News

Net profit of Kwality Pharmaceuticals rose 74.60% to Rs 25.30 crore in the quarter ended March 2026 as against Rs 14.49 crore during the previous quarter ended March 2025. Sales rose 35.81% to Rs 157.11 crore in the quarter ended March 2026 as against Rs 115.68 crore during the previous quarter ended March 2025.For the full year,net profit rose 69.01% to Rs 67.35 crore in the year ended March 2026 as against Rs 39.85 crore during the previous year ended March 2025. Sales rose 35.89% to Rs 503.08 crore in the year ended March 2026 as against Rs 370.20 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales157.11115.68 36 503.08370.20 36 OPM %24.6722.37 -23.5021.72 - PBDT36.9324.16 53 110.1372.43 52 PBT31.6719.07 66 90.3254.14 67 NP25.3014.49 75 67.3539.85 69 Powered by Capital Market - Live News

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Kwality Pharmaceuticals has received upgrade in credit ratings for bank loan facilities of the company at ICRA BBB+; Stable / ICRA A2. Further, the ratings have been removed from the �Issuer Not Cooperating� category.

Net profit of Kwality Pharmaceuticals rose 87.69% to Rs 16.01 crore in the quarter ended December 2025 as against Rs 8.53 crore during the previous quarter ended December 2024. Sales rose 46.24% to Rs 123.44 crore in the quarter ended December 2025 as against Rs 84.41 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales123.4484.41 46 OPM %24.2620.73 - PBDT28.0015.95 76 PBT23.1811.39 104 NP16.018.53 88 Powered by Capital Market - Live News

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News